
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2026-08-20HEPASCHEDULE 13D/AVincent LoPriore Increases Stake in Hepion Pharmaceuticals to 26.2% via Private PlacementsHIGH
Vincent LoPriore, the Executive Chairman of Hepion Pharmaceuticals, Inc. (HEPA), filed an amended Schedule 13D on August 20, 2026, reporting a significant increase in beneficial ownership. Jointly filed with Gravitas Capital LP and Invictus Capital Advisors Pension Plan, the reporting persons now collectively hold 26,2...
Biotechnologyownership +26.20%
Sponsored
2026-08-20Hepion Pharmaceuticals, Inc.SCHEDULE 13D/AVincent LoPriore Increases Stake in Hepion Pharmaceuticals to 26.2% via Private PlacementsDuplicateHIGH
Vincent LoPriore, the Executive Chairman of Hepion Pharmaceuticals, Inc. (HEPA), filed an amended Schedule 13D on August 20, 2026, reporting a significant increase in beneficial ownership. Jointly filed with Gravitas Capital LP and Invictus Capital Advisors Pension Plan, the reporting persons now collectively hold 26,2...
Biotechnologyownership +26.20%
Sponsored
Sponsored